PubMed Portnoi G, Chng LA, Karimi-Tabesh L, et al
Without randomized, long-term studies on the use of GLP-1 RAs in a large sample size of HS patients with a wide range of ages, comorbidities, risk factors, and sexes and without any confounding factors, it is difficult to conclusively determine whether GLP-1 RAs are a definitive treatment for HS
Yet emerging evidence suggests they may also have neuroprotective properties
"Once I was allowed to go back to the hotel the consultant said 'Just remember next time, you may not be so lucky'." 'Side effects' The products are promoted on social media and are readily available to buy online, while the BBC has also found beauty salons and tanning shops advertising them for sale
When you see tirzepatide niacinamide listed on a compounding pharmacy label, you are looking at a combination designed to address both the practical challenges of peptide stability and the theoretical opportunity for synergistic metabolic benefits